National Account Director (Midwest) at Acadia Pharmaceuticals

Field, South Australia, Australia

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Emulates Paratek’s Core Values: Resourceful, Collaborative, Passionate, Purposeful

Responsibilities

Lead and expand high-value business partnerships within designated national and strategic regional payer accounts, achieving targeted payer access with optimal profitability
Develop a robust understanding of each customer's business environment and processes, leveraging this knowledge to secure optimal formulary access and achieve performance goals
Ensure the needs of, and opportunities in, assigned accounts are communicated to Market Access leadership and other internal stakeholders so that they can be integrated into strategic planning and forecasting as appropriate
Negotiate and communicate the financial and clinical value proposition of Paratek products effectively, considering the broader impact on profitability
Design and oversee the execution of Account Business Plans using Active Account Planning for each assigned account, informed by deep insights into customer and market influences
Monitor and evaluate account progress, updating strategies and resources as necessary to maximize access, volume growth, and market share
Build and maintain strategic alliances with field-based colleagues to ensure coordinated cross-functional support for customer accounts and successful pull-through execution
Collaborate cross-functionally and act as a leader with colleagues to stay ahead of policy and legislative changes that may impact the business, allowing for proactive intervention to positively impact access and profitability of marketed products
Work closely with Sales Leadership to educate and enhance understanding of access dynamics, including identifying Key Opinion Leaders (KOLs) to advocate for access where appropriate
Regularly analyze contracted product performance and communicate updates with key stakeholders in Market Access, Legal, Commercial Operations, and Finance
Provide ongoing training for sales teams on Market Access developments that may impact shared goals, including legislative and market changes at all levels
Conduct quarterly business reviews with health plans, covering Paratek product performance, utilization data, and other critical analytics to optimize strategic alignment
Identify and allocate resources efficiently, tracking and adjusting based on evolving customer needs and market conditions

Skills

Managed Care Organizations

Pharmacy Benefit Managers

Medicaid FFS

Medicare PDPs

Formulary Access

Payer Strategy

Market Access

Account Management

Strategic Planning

Sales Operations

Cross-Functional Collaboration

Business Development

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free